We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+18.48%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$748M
AUM Growth
+$11.5M
Cap. Flow
-$43.9M
Cap. Flow %
-5.86%
Top 10 Hldgs %
21.83%
Holding
143
New
43
Increased
23
Reduced
42
Closed
33

Top Sells

Rank Stock Value
1
SITM icon
SiTime
SITM
+$17.1M
2
HALO icon
Halozyme
HALO
+$15.4M
3
LFUS icon
Littelfuse
LFUS
+$13.6M
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$12.7M
5
PLAY icon
Dave & Buster's
PLAY
+$12.2M

Sector Composition

Rank Sector Weight
1 Technology 26.34%
2 Healthcare 26.27%
3 Industrials 20.62%
4 Consumer Staples 10.04%
5 Consumer Discretionary 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASAN icon
51
Asana
ASAN
$2.13B
$6.01M 0.8%
+270,600
New +$5.81M
XMTR icon
52
Xometry
XMTR
$5.34B
$5.86M 0.78%
+103,210
New +$4.82M
BOX icon
53
Box
BOX
$4.6B
$5.74M 0.77%
235,395
-5,810
-2% -$160K
AVAV icon
54
AeroVironment
AVAV
$9.45B
$5.74M 0.77%
+68,845
New +$6.16M
SLCA
55
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$5.58M 0.75%
509,771
-160,290
-24% -$2.04M
KIDS icon
56
OrthoPediatrics
KIDS
$595M
$5.53M 0.74%
119,763
-40,860
-25% -$2M
ELF icon
57
e.l.f. Beauty
ELF
$5.8B
$5.41M 0.72%
+143,795
New +$5.19M
EXTR icon
58
Extreme Networks
EXTR
$3.15B
$5.37M 0.72%
410,881
-240,440
-37% -$3.03M
IRTC icon
59
iRhythm Holdings
IRTC
$4.2B
$5.35M 0.72%
42,710
-25,060
-37% -$3.62M
PEN icon
60
Penumbra
PEN
$12.8B
$5.07M 0.68%
+26,760
New +$4.29M
MODN
61
DELISTED
MODEL N, INC.
MODN
$5M 0.67%
+146,160
New +$4.22M
ARRY icon
62
Array Technologies
ARRY
$855M
$4.85M 0.65%
292,290
+20,535
+8% +$355K
STAA icon
63
STAAR Surgical
STAA
$1.21B
$4.81M 0.64%
68,155
-101,850
-60% -$8.72M
PRVA icon
64
Privia Health
PRVA
$2.83B
$4.69M 0.63%
+137,650
New +$5.09M
NOVA
65
DELISTED
Sunnova Energy
NOVA
$4.68M 0.63%
+211,905
New +$5.14M
CALM icon
66
Cal-Maine
CALM
$3.99B
$4.67M 0.62%
83,980
+27,865
+50% +$1.52M
BILL icon
67
BILL Holdings
BILL
$4.78B
$4.62M 0.62%
34,880
+15,945
+84% +$2.29M
FNKO icon
68
Funko
FNKO
$328M
$4.54M 0.61%
+224,325
New +$5.14M
PLMR icon
69
Palomar
PLMR
$3.45B
$4.37M 0.58%
+52,230
New +$3.83M
TMDX icon
70
Transmedics
TMDX
$2.91B
$4.31M 0.58%
103,185
-2,595
-2% -$113K
GO icon
71
Grocery Outlet
GO
$980M
$4.28M 0.57%
128,540
-83,960
-40% -$3.41M
KRTX
72
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$4.15M 0.56%
+18,455
New +$3.74M
ASO icon
73
Academy Sports + Outdoors
ASO
$2.98B
$4.1M 0.55%
+97,245
New +$4.26M
NARI
74
DELISTED
Inari Medical, Inc. Common Stock
NARI
$4.07M 0.54%
55,980
-40,210
-42% -$2.99M
PWR icon
75
Quanta Services
PWR
$101B
$4.04M 0.54%
31,721
-27,825
-47% -$3.8M

Similar funds

Lisanti Capital Growth's Q3 2022 Portfolio in Review

As of Q3 2022, Lisanti Capital Growth held 143 positions worth $748M, up 1.6% from $736M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Lisanti Capital Growth withdrew a net $43.9M in Q3 2022, closing 33 positions and reducing 42 holdings. Its most notable exit was SiTime, an estimated $17.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Lisanti Capital Growth opened a new position in Wingstop worth $15.9M.

  • Lisanti Capital Growth's largest Q3 2022 buy was Wingstop: 126,975 shares worth $15.9M.
  • Lisanti Capital Growth added most to Advanced Drainage Systems in Q3 2022, an estimated $8.48M increase.
  • Lisanti Capital Growth's biggest Q3 2022 reduction was Intra-Cellular Therapies Inc., cutting an estimated $12.7M.
  • Lisanti Capital Growth fully exited SiTime in Q3 2022, selling an estimated $17.1M.
  • Lisanti Capital Growth's ten largest holdings make up 22% of its $748M portfolio in Q3 2022.
  • Lisanti Capital Growth opened 43 new positions and closed 33 in Q3 2022.
  • Lisanti Capital Growth's portfolio value rose 1.6% quarter-over-quarter to $748M.

Based on Lisanti Capital Growth's 13F filing for Q3 2022, filed 2 Nov 2022.